Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Russell-Jones

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
Molecular and Cellular Endocrinology|December 2, 2008
Molecular, pharmacological and clinical aspects of liraglutide, a once-daily human GLP-1 analogueDavid Russell-Jones
Diabetes, Obesity & Metabolism|October 11, 2007
Insulin-associated weight gain in diabetes--causes, effects and coping strategiesDavid Russell-Jones, Rehman Khan
Diabetic Medicine : a Journal of the British Diabetic Association|July 12, 2021
100 years of physiology, discrimination and wonderDavid Russell-Jones, Roselle Herring
Postgraduate Medical Journal|June 30, 2023
Discovery of insulin 100 years onDavid Russell-Jones, Zosanglura Bawlchhim
Current Opinion in Endocrinology, Diabetes, and Obesity|May 26, 2010
The effect of growth hormone on pituitary tumour growthRoselle Herring, David Russell-Jones
Clinical Endocrinology|July 19, 2012
Recent advances in incretin-based therapiesDavid Russell-Jones, Stephen Gough
Lancet (London, England)|July 12, 2025
Use of once-weekly insulins for type 1 diabetesDavid Russell-Jones, David C Klonoff
Clinical Medicine (London, England)|October 6, 2018
Patient power - Kidd GlovesAnneka Burge, Malcolm Green, David Russell-Jones
Expert Review of Endocrinology & Metabolism|February 10, 2019
Exenatide, a GLP-1 agonist in the treatment of Type 2 diabetesDevesh Sennik, Fahad Ahmed, David Russell-Jones
Diabetes, Obesity & Metabolism|October 21, 2017
Identification of barriers to insulin therapy and approaches to overcoming themDavid Russell-Jones, Frans Pouwer, Kamlesh Khunti
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Molecular and Cellular Endocrinology|December 2, 2008
Molecular, pharmacological and clinical aspects of liraglutide, a once-daily human GLP-1 analogueDavid Russell-Jones
Diabetes, Obesity & Metabolism|October 11, 2007
Insulin-associated weight gain in diabetes--causes, effects and coping strategiesDavid Russell-Jones, Rehman Khan
Diabetic Medicine : a Journal of the British Diabetic Association|July 12, 2021
100 years of physiology, discrimination and wonderDavid Russell-Jones, Roselle Herring
Postgraduate Medical Journal|June 30, 2023
Discovery of insulin 100 years onDavid Russell-Jones, Zosanglura Bawlchhim
Current Opinion in Endocrinology, Diabetes, and Obesity|May 26, 2010
The effect of growth hormone on pituitary tumour growthRoselle Herring, David Russell-Jones
Clinical Endocrinology|July 19, 2012
Recent advances in incretin-based therapiesDavid Russell-Jones, Stephen Gough
Lancet (London, England)|July 12, 2025
Use of once-weekly insulins for type 1 diabetesDavid Russell-Jones, David C Klonoff
Clinical Medicine (London, England)|October 6, 2018
Patient power - Kidd GlovesAnneka Burge, Malcolm Green, David Russell-Jones
Expert Review of Endocrinology & Metabolism|February 10, 2019
Exenatide, a GLP-1 agonist in the treatment of Type 2 diabetesDevesh Sennik, Fahad Ahmed, David Russell-Jones
Diabetes, Obesity & Metabolism|October 21, 2017
Identification of barriers to insulin therapy and approaches to overcoming themDavid Russell-Jones, Frans Pouwer, Kamlesh Khunti
Pageof 6